242 filings
Page 6 of 13
8-K
21putfsf
13 Jan 20
Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors
4:16pm
8-K
j83ppesy1m 4lzg6
20 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
8-K
hs5vxuqi xhckwt0g
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
k01b64s1i3fljo
11 Dec 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3:15pm
8-K
igmkz7uu
10 Dec 19
Presentation Made by Chief Scientific Officer John Gainer at the Inaugural Glioblastoma Drug Development Summit
4:25pm
8-K
0eol1
10 Dec 19
Regulation FD Disclosure
8:44am
8-K
xm7qx8
19 Nov 19
Chief Scientific Officer Dr. John Gainer to Present at Inaugural Glioblastoma Drug Development Summit
4:49pm
8-K
grhh2z
15 Nov 19
Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering
4:06pm
8-K
kp428
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
096c3o buo
12 Nov 19
Diffusion Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
8:19am
8-K
chaz2u 7q917pr
13 Jun 19
Submission of Matters to a Vote of Security Holders
12:29pm
8-K
6q3sayqtem
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm
8-K
5q7pat6mruzosa on9f
9 May 19
Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
4:02pm
8-K
rscpfodw72iynttvtj
18 Jan 19
Departure of Directors or Certain Officers
4:04pm
8-K
1g8u1w6k8
14 Dec 18
Material Modifications to Rights of Security Holders
8:32am
8-K
an3v45t
14 Nov 18
Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
4:02pm
8-K
m9ofr08
27 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
r8sf157sj5
31 Aug 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
iqe15atnrp6knq s9
14 Aug 18
Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
12:00am
8-K
y5921 fa32aaje2m
15 Jun 18
Submission of Matters to a Vote of Security Holders
4:03pm